Cures Within Reach
Overview
Cures Within Reach is a US-based non-profit that funds clinical repurposing trials to test already approved therapies for unsolved diseases.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Mitochon Pharmaceuticals | May 2016 | Seed | Co-investor |
For institutional investors. Book with your work email.
Key People
Barbara Goodman
President & CEO
Clare Thibodeaux
Vice President, Scientific Affairs
CJ Wright
Director, Scientific Affairs
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Cures Within Reach based?
Cures Within Reach is headquartered in Chicago, Illinois, United States.
When was Cures Within Reach founded?
Cures Within Reach was founded in 2005.
How many portfolio companies does Cures Within Reach have?
Cures Within Reach has 2 portfolio companies in Caplight's dataset.
What are some companies in Cures Within Reach's portfolio?
Portfolio companies visible on Caplight include Mitochon Pharmaceuticals.
What was Cures Within Reach's most recent investment shown here?
Cures Within Reach's most recent investment in this portfolio sample was in Mitochon Pharmaceuticals in 2016.
What sectors does Cures Within Reach focus on?
Cures Within Reach focuses on Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Cures Within Reach focus on?
Cures Within Reach typically invests at the Early stage.
What is Cures Within Reach's AUM?
Cures Within Reach's assets under management are estimated between $7.5M and $7.5M.